Synaptogenix, Inc. (NASDAQ:SNPX – Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 33,700 shares, a growth of 183.2% from the March 31st total of 11,900 shares. Based on an average daily trading volume, of 48,500 shares, the short-interest ratio is currently 0.7 […]
NEW YORK, April 24, 2024 /PRNewswire/ Synaptogenix, Inc. , an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that it received notice.
Synaptogenix, Inc. (NASDAQ:SNPX) Short Interest Update kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.